REFERENCES
- Craig WA, Gudmundson S. The postantibiotic effect. In: V. Lorian (ed.), Antibiotics in Laboratory Medicine. Baltimore: The Williams & Wilkins Co. 1986: 515-536.
- MacDonald PJ, Wetherall BL, Kunin CM. Persistent effects of antibiotics on Staphylococcus aureus after exposure for limited periods of time. J Infect Dis 1977; 135: 217–223.
- Bustamente CI, Drusano GL, Tatem BA, Standiford HC. Postantibiotic effect of imipenem on Pseudomonas aeruginosa. Antimicrob Agents Chemother 1984; 26: 678–682.
- Guan L, Burnham JC. Postantibiotic effect of CI-960, enoxacin and ciprofloxacin on Escherichia coli: effect on morphology and hemolysin activity. J Antimicrob Chemother 1992; 29: 529–538.
- Isaksson B, Nilsson L, Mailer R, Soren L. Postantibiotic effect of aminoglycosides on gram-negative bacteria evaluated by a new method. J Antimicrob Chemother 1988; 22: 23–33.
- Rescott DL, Nix DE, Holden P, Schentag JJ. Comparison of two methods for determining in vitro postan-tibiotic effects of three antibiotics on Escherichia coll. Antimicrob Agents Chemother 1988; 32: 450–453.
- Maggiolo F, Taras A, Frontespezi S, et al. Pharmacodynamic effects of subinhibitory concentrations of imipenem on Pseudomonas aeruginosa in an in-vitro dynamic model. Antimicrob Agents Chemother 1994; 38: 1416–1418.
- Odenholt-Tornqvist I, Holm SE, Cars O. Pharmacodynamic effects of subinhibitory antibiotic concentrations. Scand J Infect Dis 1991; suppl. 74: 94-101.
- Odenholt-Tornqvist I, Lowdin E, Cars O. Pharmacodynamic effects of subinhibitory concentrations of 13-lactam antibiotics in vitro. Antimicrob Agents Chemother 1991; 35: 1834-1839.
- Odenholt-Tornqvist I, Lowdin E, Cars O. Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin and amikacin. Antimicrob Agents Chemother 1992; 36: 1852–1858.
- Dalhoff A, Petersen U, Endermann R. In vitro activity of Bay 12-8039, a new 8-methoxyquinolone. Chemotherapy 1996; 42: 410–425.
- Bauernfeind A. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. J Antimicrob Chemother 1997; 40: 639–651.
- Klugman KP, Capper T. Concentration dependent killing of antibiotic-resistant pneumococci by the methoxyquinolone moxifloxacin. J Antimicrob Chemother 1997; 40: 797–802.
- Brueggemann AB, Kugler K, Doern GV. In vitro activity of Bay 12-8039, a novel 8-methoxyquinolone, compared to the activities of six fluorquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Antimicrob Agents Chemother 1997; 41: 1594–1597.
- Fass RJ. In vitro activity of Bay 12-8039, a new 8-methoxyquinolone. Antimicrob Agents Chemother 1997; 41: 1818-1824.
- Woodcock JM, Andrews JM, Boswell FJ, Brenwald NP, Wise R. In vitro activity of Bay 12-8039, a new fluo-rquinolone. Antimicrob Agents Chemother 1997; 41: 101–106.
- Stass H, Schuehly U, Wingender W. Pharmacokinetics, safety and tolerability of 600 mg Bay 12-8039 administered once daily over 10 days. 8th ESCMID, Lausanne, Swiss 25-28 May 1997, abstract P387.
- Grasso S, Meinardi G, de Carneri I, Tamassia V. New in vitro model to study the effect of antibiotic concentration and rate of elimination of antibacterial activity. Antimicrob Agents Chemother 1978; 13: 570–576.
- Maggiolo F, Taras A, Frontespezi S, Bottari F, Legnani MC, Suter F. Bactericidal activity of two different dosage regimens of imipenem in an invitro dynamic model. J Antimicrob Chemother 1993; 32: 295–300.
- Kunin CM. Dosage schedules of antimicrobial agents: a historical review. Rev Infect Dis 1981; 3: 4–11.
- Neu HC. Current practices in antimicrobial dosing. Rev Infect Dis 1981; 3: 12–18.
- Vogelman B, Craig WA. Kinetics of antimicrobial activity. J Pediatr 1986; 108: 835–840.
- Greenwood D. In vitro veritas? Antimicrobial susceptibility tests and their clinical relevance. J Infect Dis 1981; 144: 380–385.
- Odenholt-Tornqvist I, Loedwin E, Cars O. Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin and amikacin. Antimicrob Agents Chemother 1992; 36: 1852–1858.
- Forrest A, Ballow CH, Nix DE, Birmingham MC, Gross TF, Schentag JJ. Population pharmacodynamics of ciprofloxacin. 31” ICAAC Chicago, USA, 29 Sept.-2 Oct. 1991, abstract 602. 1991, abstract 602.